InvestorsHub Logo
Followers 35
Posts 6426
Boards Moderated 0
Alias Born 07/07/2002

Re: None

Wednesday, 12/19/2012 8:43:28 PM

Wednesday, December 19, 2012 8:43:28 PM

Post# of 22684
Looks like ARNA will get takeover speculation at some point also.

VVUS-Shares of Vivus (VVUS) are active in the post session on speculation that Johnson & Johnson (JNJ) and AstraZeneca (AZN) are considering a takeover of the drug developer due to the company's obesity drug Qsymia. Pfizer (PFE) may also take an interest should VVUS come under takeover attack, because obestity drugs are a hot item at present - with over 78M obese adults in the U.S. alone. Deal-watchers are skeptical however, noting that any deal with a chance of success would need to be in the $30-plus per share range. VVUS +1.3% AH.

Manny